Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2016

Feb 24, 2016

30339_dirs_2016-02-24_109fe725-965d-469d-875a-80f864dd0620.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-02-23

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-23 Common Stock M 9458.0000 $21.2200 Acquired 20911.0285 Direct
2016-02-23 Common Stock M 6584.0000 $29.5550 Acquired 27495.0285 Direct
2016-02-23 Common Stock S 6584.0000 $59.4037 Disposed 20911.0285 Direct
2016-02-23 Common Stock S 9458.0000 $59.4037 Disposed 11453.0285 Direct
2016-02-24 Common Stock M 3616.0000 $47.3400 Acquired 15069.0285 Direct
2016-02-24 Common Stock S 3616.0000 $59.6569 Disposed 11453.0285 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-23 Stock Option (Right to Buy) $29.5550 M 6584.0000 Disposed 2023-02-19 Common Stock (6584.0000) Direct
2016-02-23 Stock Option (Right to Buy) $21.2200 M 9458.0000 Disposed 2022-02-21 Common Stock (9458.0000) Direct
2016-02-23 Stock Option (Right to Buy) $59.6400 A 13012.0000 Acquired 2026-02-23 Common Stock (13012.0000) Direct
2016-02-24 Stock Option (Right to Buy) $47.3400 M 3616.0000 Disposed 2024-02-24 Common Stock (3616.0000) Direct

Footnotes

F1: This was multiple transactions on the same date with prices in the range of $59.40 to $59.43. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.

F2: This was multiple transactions on the same date with prices in the range of $59.65 to $59.68. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.